References
- Herbert PN, Assmann GF, Gotto AM, Fredrickson DS. Familial lipoprotein deficiency: Abetali-poproteinemia. hypobetalipoproteinemia and Tangier disease. The Metabolic Basis of Inherited Disease, JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, MS Brown. McGraw-Hill Book Company, New York 1983; 589–621
- Leren P, Foss OP, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 1980; ii: 4–6
- Leren P, Foss OP, Helgeland A, Hjermann I, Holme I. Effect of pindolol and hydrochlor-othiazide on blood lipids. Clin Trial J 1981; 18: 254–61
- Helgeland A, Hjermann I, Leren P, Enger SC, Holme I. High-density lipoprotein cholesterol and antihypertensive drugs. The Oslo Study. Br Med J 1978; 2: 403
- Grimm RH, Jr, Leon AS, Hunnighake DP, Lenz K, Hannan P, Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med 1981; 94: 7–11
- Goldstein JL, Brown MS. Familial hyper-cholesterolemia. The Metabolic Basis of Inherited Disease, JB Stanbury, JB Wyngaarden, DS Fredrickson, JL Goldstein, MS Brown. McGraw-Hill Book Company, New York 1983; 672–712
- Leren TP. Doxazosin increases low density lipoprotein receptor activity. Acta Pharmacol Toxicol 1985; 56: 269–72
- Lowenstein J, Neusy AJ. Effects of prazosin and propranolol on serum lipids in patients with essential hypertension. Am J Med 1984, Suppl. 2A: 79–84
- Rouffy JM, Jaillard J. Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients. Am J Med 1984, Suppl. 2A: 105–8
- Kovanen P, Brown MS, Basu SK, Bilheimer DW, Goldstein JL. Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc Natl Acad Sci. USA 1981; 78: 1396–400
- Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 1980; 36: 261–8
- Tanzawa K, Shimada Y, Kuroda M, Tsujita Y, Arai M, Watanabe H. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett 1980; 118: 81–4
- Hills M, Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8: 7–20
- Mistry P, Miller NE, Laker M, Hazzard WR, Lewis B. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reduc-tase activity in blood mononuclear cells. J Clin Invest 1981; 67: 493–502
- Torvik D, Madsbu HP. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension. Br J Clin Pharmacol 1986; 21(Suppl. 1)69–75
- Lehtonen A, Himanen P, Saraste M, Niitymaki K, Marniemi J. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins. Br J Clin Pharmacol 1986; 21(Suppl. 1)77–82